Success Metrics

Clinical Success Rate
84.6%

Based on 11 completed trials

Completion Rate
85%(11/13)
Active Trials
0(0%)
Results Posted
18%(2 trials)
Terminated
2(13%)

Phase Distribution

Ph phase_4
1
7%
Ph not_applicable
3
20%
Ph phase_2
2
13%
Ph phase_3
5
33%

Phase Distribution

0

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
5(45.5%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
3(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.6%

11 of 13 finished

Non-Completion Rate

15.4%

2 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Completed(11)
Terminated(2)
Other(2)

Detailed Status

Completed11
Terminated2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
84.6%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (18.2%)
Phase 35 (45.5%)
Phase 41 (9.1%)
N/A3 (27.3%)

Trials by Status

terminated213%
completed1173%
unknown213%

Recent Activity

0 active trials
Showing 5 of 15
unknown

Risk Factors and Machine Learning Model for Diuretics Related Acute Kidney Injury

NCT05527054
completedphase_2

Empagliflozin as a Novel Therapy in Refractory Ascites

NCT05430243
unknownnot_applicable

Quantifying Congestion by Ultrasound

NCT05090137
completednot_applicable

Effects of Fluid Balance Control in Critically Ill Patients

NCT02765009
completednot_applicable

To Study the Safety and Efficacy of Midodrine With Albumin Versus Albumin Alone in Hepatic Hydrothorax

NCT03645642
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT05527054

Risk Factors and Machine Learning Model for Diuretics Related Acute Kidney Injury

Unknown
NCT05430243Phase 2

Empagliflozin as a Novel Therapy in Refractory Ascites

Completed
NCT05090137Not Applicable

Quantifying Congestion by Ultrasound

Unknown
NCT02765009Not Applicable

Effects of Fluid Balance Control in Critically Ill Patients

Completed
NCT03645642Not Applicable

To Study the Safety and Efficacy of Midodrine With Albumin Versus Albumin Alone in Hepatic Hydrothorax

Completed
NCT03395951

Mean Systemic Filling Pressure Continuous Diuretics Critical Care Patients

Completed
NCT01370564Phase 2

Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures

Completed
NCT01290146Phase 3

ELEVATE Early LEvosimendan Vs Usual Care in Advanced Chronic hearT failurE

Terminated
NCT01896661Phase 3

Effect of Antihypertensive Agents Over Sleep Apnea

Completed
NCT00000485Phase 3

Hypertension Detection and Follow-up Program (HDFP)

Completed
NCT00000487Phase 3

Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease (MRFIT)

Completed
NCT02240641

Effect of Caldine® on Renal Function in Balanced Hypertension

Terminated
NCT02215733

The Use of Angiotensin Receptor Blockers and the Risk of Cancer

Completed
NCT00391846Phase 4

Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone

Completed
NCT01138683Phase 3

Cardiorenal Interactions During Treatment of Acute Decompensated Heart Failure: Diuretics Versus Ultrafiltration

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15